Enzo Biochem Granted European Patent For Displacer Technology To Treat Gene Abnormalities
Methodology Could Make Possible Modification or Corrections of Cell Mutations
15-Jun-2004 -
Farmingdale. Enzo Biochem, Inc. , announced that the European Patent Office has granted it a patent that describes, in part, a method of performing targeted delivery and incorporation of genetic material into chromosomal DNA without using a viral vector, thus making possible the editing and ...
acids
affinity chromatography
anemia
+8